Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
A
APTA
vs
F
FTSE All Share Index
Over the past 12 months, APTA has outperformed FTSE All Share Index, delivering a return of -64% compared to FTSE All Share Index's 0% growth.
Stocks Performance
APTA vs FTSE All Share Index
Performance Gap
APTA vs FTSE All Share Index
Performance By Year
APTA vs FTSE All Share Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Aptamer Group PLC
Glance View
Aptamer Group PLC develops aptamers, which are short synthetic molecules that can bind to a target in a very specific way, much like an antibody does. The company sells aptamer discovery and development services to life science, diagnostic, and pharmaceutical customers who need custom binding molecules for tests, research tools, or therapeutic programs. Its customers use these aptamers to recognize proteins or other biological targets in lab assays, diagnostic tests, and drug discovery work. Aptamer Group makes money by charging for research and development projects, custom design work, and related licensing or commercial agreements tied to the aptamers it creates. What makes the business different is that it sits in the middle of the move from traditional antibody reagents to synthetic alternatives. Aptamers are made in the lab rather than in animals, which can make them easier to engineer for a specific target and easier to reproduce consistently. That gives Aptamer Group a role as a specialist supplier of custom molecular binders rather than a mass-market biotech drug maker.